Probiotic supplement for multiple sclerosis
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study tests whether adding a probiotic supplement to your usual MS treatment (or to no treatment) can help manage relapsing-remitting multiple sclerosis. It aims to see if the probiotic is safe and beneficial as an add-on therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You have relapsing-remitting multiple sclerosis (RRMS).
- Your disability level is moderate (EDSS score of 5.5 or less).
- You are either on a stable first-line treatment (like teriflunomide, dimethyl fumarate, interferon-beta, or glatiramer acetate) for at least 24 weeks, or you have chosen not to take any MS treatment after discussing it with your doctor.
- You have not had an MS relapse in the last month and have not used corticosteroids in the last month.
- You have not taken antibiotics or probiotic supplements in the last three months, and you do not have any bowel disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental oral drug, PRO-1562, in two parts: first in healthy volunteers to check safety, then in people with relapsing multiple sclerosis to see if it can reduce disease activity. It may offer a new, convenient treatment option.
This trial tests an oral supplement called indole-3-propionic acid to see if it can help people with relapsing-remitting multiple sclerosis (RRMS). It involves taking the supplement daily and having regular MRI scans to monitor your MS.
This trial tests whether adding Probiotic 6600 to your usual treatment can help manage colitis, including ulcerative colitis or Crohn's disease. It aims to see if the probiotic improves symptoms and is safe to use.
This study tests whether a daily probiotic supplement (LH76) can improve gut health. Participants will take either the probiotic or a placebo for a period and provide samples to see how it affects their body.
This trial tests whether adding a synbiotic (a mix of probiotics and prebiotics) along with standard Parkinson’s medicines can improve symptoms or health outcomes. It’s mainly for adults with Parkinson’s disease at earlier to mid-stages who take dopamine replacement therapy.
This trial tests a daily probiotic supplement's effect on digestion, immune health, and overall well-being. If you're a healthy adult, you may help discover if this product can make you feel better day-to-day.
Hear when a new Multiple sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.